Last update 02 May 2024
BioNTech SE

BioNTech SE

Public Company|
2007|
Rheinland-Pfalz, Germany
|
1,000-5,000
| NASDAQ: BNTX|

Overview

Basic Info

Introduction
BioNTech SE is a company that specializes in developing immunotherapies for the treatment of cancer and other severe illnesses. Their product pipeline includes BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs, and Next-Gen CP Immunomodulators. The company was established in 2008 by Christopher Huber, Oezlem Tuereci, and Ugur Sahin and is based in Mainz, Germany.

Tags

Neoplasms
Infectious Diseases
Respiratory Diseases
mRNA vaccine
Therapeutic vaccine
Prophylactic vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
mRNA vaccine35
Prophylactic vaccine7
Therapeutic vaccine7
Vaccine5
Bispecific antibody5

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 May 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
16
Preclinical
Phase 1 Clinical
20
22
Phase 2 Clinical
Phase 3 Clinical
4
2
Approved
Other
19
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free